Table 2.
Concentration of MIF in normal and pathological samples.
| Number of patients | Placental tissue (pg/mg) | Fetal membranes (pg/mg) | Umbilical cord tissue (pg/mg) | P valuea | |
|---|---|---|---|---|---|
| Controls | 8 | 163,8* (112,4) | 87,7 (88,1) | 72,3* (46,4) | *0,034 |
| All PE | 20 | 119,5 (80,3) | 112,8 (105,5) | 85,6 (58,2) | n.s. |
| PE-AGA | 10 | 142,8* (94,6) | 162,2° (116,7) | 60,9∗° (48,4) | *0,006; °0,005 |
| PE-FGR | 10 | 93,7 (51,9) | 58,0° (54,5) | 107,5° (58,5) | °0,038 |
PE: preeclampsia.
PE-AGA: preeclamptic pregnancies with appropriate-for-gestational-age newborns.
PE-FGR: preeclamptic pregnancies with fetal growth restriction.
n.s.: not significant.
a P values were calculated by ANOVA test, followed by Tamhane test for pair-wise comparison.
*Comparison between placental and umbilical cord MIF concentrations.
°Comparison between fetal membranes and umbilical cord MIF concentrations.